Skip to main content
. Author manuscript; available in PMC: 2015 Oct 6.
Published in final edited form as: Drug Resist Updat. 2014 Oct 6;17(0):105–123. doi: 10.1016/j.drup.2014.10.001

Table 1.

Selected data from settings with statistically significant linear trends in estimated per capita rates of MDR-TB among new notified TB cases

MDR-TB trend (annual % change)* Number of years of data** Type of data Average*** TB case detection rate (%)[26] Percent of new TB cases receivin g DST (%)[42] Percent of new TB cases that are MDR (%)[42] Percent of retreatment TB cases that are MDR (%)[42] Average*** number of estimated MDR-TB among notified TB cases[42] Estimated gap in MDR-TB treatment (% of estimated cases not treated)[38, 42] Average*** annual estimated TB incidence (per 100,000)[26] Average*** HIV prevalence (%)[43] Average*** population size[12] Average*** GDP per capita (US$)[44] Average*** total health expenditure per capita (US$)[45]
Botswana 20.71 4 Survey 60 9 9.6 25.1 823 61 820 24.8 1778702 3869 188
Mary El (Russian Fed) 19.18 5 Surveillance 70 42 16.6 40.6 n/a 59 123 0.6 702283 5412 309
Karelia (Russian Fed) 16.05 3 Surveillance 57 685388
Ivanovo (Russian Fed) 15.79 7 Surveillance 58 1144743
Tomsk Russian Fed) 14.05 11 Surveillance 72 1002691
Estonia -3.34 16 Surveillance 87 70 16.0 45.7 72 23 45 0.9 1354230 10021 567
Latvia -4.32 16 Surveillance 79 72 10.5 31.9 134 11 84 0.5 2320459 7613 1710
Portugal -8.50 13 Surveillance 87 38 1.4 6.6 45 51 102 0.7 10541469 18150 1835
Hong Kong -8.52 13 Surveillance 87 53 0.9 6.6 6 54 76 n/a 6756500 27799 n/a
Macao -14.81 8 Surveillance 89 74 1.9 5.2 46 0 37 n/a 518487 42039 n/a
*

calculated in current analysis

**

see Appendix Table for data from all settings

***

Averages are calculated over years for which MDR trend data were available for each setting